share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  07/12 13:27
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction took place on 07/11/2024. However, the announcement did not disclose specific details regarding the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Bourla after the transaction was not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
Pfizer Inc. (PFE) has reported a transaction involving its Chairman & CEO, Albert Bourla. The transaction took place on 07/11/2024. However, the announcement did not disclose specific details regarding the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Bourla after the transaction was not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
輝瑞公司(PFE)報告了其董事長兼首席執行官Albert Bourla的一筆交易。該交易發生在2024年07月11日。但是,公告未披露有關轉讓股份數量、股份性質、交易價格或股份總價值的具體細節。此外,Bourla交易後持有的股份數量也未提供。建議投資者等待進一步詳情以充分評估此交易對他們的投資決策的影響。
輝瑞公司(PFE)報告了其董事長兼首席執行官Albert Bourla的一筆交易。該交易發生在2024年07月11日。但是,公告未披露有關轉讓股份數量、股份性質、交易價格或股份總價值的具體細節。此外,Bourla交易後持有的股份數量也未提供。建議投資者等待進一步詳情以充分評估此交易對他們的投資決策的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息